digital therapeutics

News

App to support people with depression launches in GB

A smartphone app for depression developed by Otsuka and Click Therapeutics has been launched in Great Britain, its first European market.

News

Digital player Hinge Health rises sharply after NYSE debut

In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO.

News

Digital therapy for Tourette syndrome backed for NHS use

A digital therapy to reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use by the NHS for the first time.

News

Despite US turmoil, Hinge Health pushes ahead with IPO

Digital health firm Hinge has published a new prospectus for its IPO, shrugging off the weakness in US stock markets caused by Trump's tariffs.

News

FDA clears first migraine DTx from Click Therapeutics

Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.

Patients

Reuters pharmaUS 25 Brian Hilberdink Feature

New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an...

At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.

App to support people with depression launches in GB

Digital player Hinge Health rises sharply after NYSE debut

Digital therapy for Tourette syndrome backed for NHS use

Despite US turmoil, Hinge Health pushes ahead with IPO

FDA clears first migraine DTx from Click Therapeutics

New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

digital therapeutics

Editor's Picks